|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
1999-2-2
|
|
pubmed:abstractText |
A novel series of pentafluorobenzenesulfonamides has been shown to inhibit the growth of a variety of human tumor cell lines. Among the cell types against which these agents were evaluated were the multidrug resistant (MDR) cell lines MCF-7/ADR and P388/ADR. The cytotoxic activity of members of this series of compounds was not affected by the multidrug resistant pump in MCF-7/ADR or P388/ADR cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0960-894X
|
|
pubmed:author |
pubmed-author:BaeuerleP APA,
pubmed-author:BaichwalVV,
pubmed-author:BeckmannHH,
pubmed-author:CassMM,
pubmed-author:ClarkD LDL,
pubmed-author:FarrellR PRP,
pubmed-author:KIDDR ARA,
pubmed-author:LearnedR MRM,
pubmed-author:MAHH,
pubmed-author:MedinaJ CJC,
pubmed-author:RocheDD,
pubmed-author:RosenTT,
pubmed-author:ShawKK
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
6
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2653-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9873597-Antineoplastic Agents,
pubmed-meshheading:9873597-Drug Resistance, Multiple,
pubmed-meshheading:9873597-Drug Resistance, Neoplasm,
pubmed-meshheading:9873597-Drug Screening Assays, Antitumor,
pubmed-meshheading:9873597-Fluorobenzenes,
pubmed-meshheading:9873597-Humans,
pubmed-meshheading:9873597-Phenotype,
pubmed-meshheading:9873597-Sulfonamides,
pubmed-meshheading:9873597-Tumor Cells, Cultured
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Novel antineoplastic agents with efficacy against multidrug resistant tumor cells.
|
|
pubmed:affiliation |
Tularik Inc., South San Francisco, CA 94080, USA.
|
|
pubmed:publicationType |
Journal Article
|
